Course Description

This webinar is intended for the registered nurse, clinician, and health care worker tasked with the care and case management of the TB patient.

Course Objectives:

Upon completion of this training, participants will be able to:

• Discuss CDC’s guidelines regarding the use of a new regimen for the treatment of latent tuberculosis infection (LTBI).
  • Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat LTBI.

Course Outline: 

• Review of the recommendations by CDC
• Question and Answer session

Question and Answer session:

This webinar ends with a question and answer session about the regimen.  Questions covered are vitamin B6 supplementation; minimum/maximum # days between weekly doses and how many weeks is needed to be considered completing the 12 week regimen; DOT by private providers and in non-traditional settings; monthly clinical assessment and clinical monitoring needed; lab work for evaluation and follow-up; blood pressure monitoring; HIV/TB and starting ART; pregnancy occurring during treatment with this regimen; special considerations for children; using the regimen in other immune compromised individuals such as those on chemotherapy, prednisone, and those on treatment for rheumatoid arthritis; and prioritizing who should get the regimen.

Keywords:  TB, Tuberculosis, active TB disease, TB disease, treatment of disease, Mtb, M. tb, M. tuberculosis, Mycobacterium tuberculosis, M. tb complex, TB complex, M. tuberculosis complex, Latent TB Infection, TB infection, Latent Tuberculosis Infection, 3 month INH or RPT regimen, 3 month Isoniazid rifapentine regimen